ST2 elevation in heart failure, predictive of a high early mortality

BACKGROUND: Soluble suppression of tumorigenicity-2 (sST2) is a novel biomarker shown to be useful for prognostic assessment in heart failure (HF). However, very limited data exists about its prognostic utility in patients with HF in India. METHODS: We studied 150 patients [mean age 67.7 ± 13.3, 93...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Jamshed J., Digrajkar, Aarti, Das, Barnali, Bansal, Manish, Toomu, Avinash, Maisel, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical and Preventive Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306350/
https://www.ncbi.nlm.nih.gov/pubmed/30580851
http://dx.doi.org/10.1016/j.ihj.2018.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306350/
https://www.ncbi.nlm.nih.gov/pubmed/30580851
http://dx.doi.org/10.1016/j.ihj.2018.08.019

Ejemplares similares